[Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke].

Autor: Zhuravleva MV; Research Centre for Examination of Medical Devices, Moscow, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Shchukin IA; Pirogov Russian National Research Medical University, Moscow, Russia., Fidler MS; Pirogov Russian National Research Medical University, Moscow, Russia., Prokofiev AB; Research Centre for Examination of Medical Devices, Moscow, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Serebrova SY; Research Centre for Examination of Medical Devices, Moscow, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Vasyukova NS; Federal Scientific Center - All-Russian Scientific Research Institute of Experimental Veterinary Medicine named after K.I. Skryabin and Ya.R. Kovalenko, Moscow, Russia., Demchenkova EY; Research Centre for Examination of Medical Devices, Moscow, Russia., Arkhipov VV; Research Centre for Examination of Medical Devices, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2020; Vol. 120 (12. Vyp. 2), pp. 60-66.

The Mechanism of Action of Ethoxidol on Oxidative Stress Indices in Heart Failure and Hypotension.

Autor: Kukes VG; Academician of the Russian Academy of Sciences, Professor, Department of Clinical Pharmacology and Propedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia; Head of the Scientific Direction 'Pharmacology', Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, 8, Bld. 2, Petrovsky Boulevard, Moscow, 127051, Russia., Parfenova OK; Student, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia., Romanov BK; Deputy Director General on Scientific Work, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, 8, Bld. 2, Petrovsky Boulevard, Moscow, 127051, Russia., Prokofiev AB; Professor, Department of Clinical Pharmacology and Propedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia; Director of the Clinical Pharmacology Center, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, 8, Bld. 2, Petrovsky Boulevard, Moscow, 127051, Russia., Parfenova EV; Professor, Corresponding Member of the Russian Academy of Sciences, Deputy Director General, National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation, 15A 3 Cherepkovskaya St., Moscow, 121552, Russia; Director of the Institute of Experimental Cardiology, National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation, 15A 3 Cherepkovskaya St., Moscow, 121552, Russia., Sidorov NG; Student, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia., Gazdanova AA; Associate Professor, Department of Clinical Pharmacology and Propedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia., Pavlova LI; Associate Professor, Department of Clinical Pharmacology and Propedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia., Zozina VI; PhD Student, Department of Clinical Pharmacology and Propedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia., Andreev AD; Student, Medical Faculty, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia., Aleksandrova TV; Senior Analyst, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, 8, Bld. 2, Petrovsky Boulevard, Moscow, 127051, Russia., Chernova SV; Associate Professor, Department of Pharmaceutical and Toxicological Chemistry named after A.P. Arzamastsev, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia., Ramenskaya GV; Director, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia; Head of the Department of Pharmaceutical and Toxicological Chemistry named after A.P. Arzamastsev, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Malaya Trubetskaya St., Moscow, 119991, Russia.

Publikováno v: Sovremennye tekhnologii v meditsine [Sovrem Tekhnologii Med] 2020; Vol. 12 (2), pp. 67-72.

[Novel Possibilities in Pharmacotherapy of Patients With Chronic Heart Failure].

Autor: Zhuravleva MV; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Prokofiev AB; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Shih EV; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Serebrova SY; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Gorodetskaya GI; I.M. Sechenov First Moscow State Medical University (Sechenov University).

Publikováno v: Kardiologiia [Kardiologiia] 2018 Oct (10), pp. 88-95.

[PERSONALIZED MEDICINE IN INTERNAL MEDICINE].

Autor: Kukes VG, Marinin VF, Olefir YV, Ramenskaya GV, Lazareva NB, Smirnov VV, Zhuravleva MV, Prokofiev AB, Shih EV, Zhestovskaia AS, Rumyantsev NA, Mandich DV, Goroshko OA

Publikováno v: Klinicheskaia meditsina [Klin Med (Mosk)] 2017; Vol. 95 (3), pp. 197-200.

[THE FEATURES OF SECRETION AND STOMACH MOTOR PROCESSES IN PATIENTS WITH DUODENAL ULCERS AS A CAUSE FOR REDUCING BIOAVAILABILITY OF PROTON PUMP INHIBITORS].

Autor: Serebrova SY, Zhuravleva MV, Prokofiev AB, Starodubtsey A K

Publikováno v: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology [Eksp Klin Gastroenterol] 2015 (9), pp. 8-13.